Review: "The Product is the Process – Is it?" Manufacturing and Translation of ATMPs and Tissue- & Cell-based products

An event held in cooperation with the Biotechnologieverbund Berlin-Brandenburg e.V., BBB; the Paul-Ehrlich-Institut; the Central Authority of the Länder for Health Protection with regard to Medicinal Products and Medical Devices, ZLG; the German Stem…

2 Min
More

Charité study shows that algorithm is equivalent to standard of care treatment

Deep brain stimulation (DBS) is an established treatment option for patients suffering from Parkinson's disease. In a neurosurgical procedure two electrodes are implanted in the brain to permanently stimulate specific brain regions. Setting the…

4 Min
More

Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) has discovered an unknown mechanism for how “starvation response” in body cells is triggered

Body cells burn off fat reserves when nutrient supply from food ceases. A team led by Professor Volker Haucke and Dr. Wonyul Jang from the Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) has now discovered a previously unknown mechanism…

3 Min
More

Silvia Vignolini appointed as new and first female Director of MPICI

New appointment

Prof Silvia Vignolini, Ph.D. is founding the new Department "Sustainable and Bio-inspired Materials" at the Max Planck Institute of Colloids and Interfaces (MPICI). On January 1st, the top physicist will move to Potsdam from the…

2 Min
More

DSM chooses LabTwin to advance their digitalization strategy in Science & Innovation with the latest voice and AI solutions.

DSM rolls out Labtwin's AI and voice powered digital lab assistant

Today, Royal DSM N.V., a global company specializing in health, nutrition, and sustainable living, and LabTwin GmbH, the leading voice and AI-powered digital lab assistant, announce…

3 Min
More

Charité study discovers brain network that alleviates symptoms when stimulated

Alzheimer’s disease is the most common cause of dementia, but it is not easily treatable. One potential therapy is deep brain stimulation delivered by a kind of pacemaker. A team of researchers at Charité – Universitätsmedizin Berlin has found that…

3 Min
More

Therabest and Glycotope to assess Therabest’s iPSC-derived NK cell product TB-100 in combination with Glycotope’s GT-00AxIL15 immuno-cytokine for development in triple negative breast cancer

Therabest and Glycotope to assess Therabest’s iPSC-derived NK cell product TB-100 in combination with Glycotope’s GT-00AxIL15 immuno-cytokine for development in triple negative breast cancer

4 Min
More

4C Accelerator Tübingen: Qualification program for people interested in founding & startups for business model development up to "investor readiness" through the networked elaboration of the 4Cs of the medical life sciences

We specialize in promoting medical innovations. That’s why we know: Life science startups have to overcome higher hurdles than startups from other industries. At the same time, however, there are rarely experts in these critical areas in the founding…

2 Min
More

OMEICOS Therapeutics Announces Expansion of OMT-28 Clinical Development Program into Primary Mitochondrial Diseases

OMT-28’s established safety profile, biomarker data, and funding secured from existing investors enable swift transition into a Phase II clinical study

2 Min
More

Interview | Prof. Dr. rer. nat. Heyo K. Kroemer, Chief Executive Officer of Charité – Universitätsmedizin Berlin

Diverse challenges and opportunities

1 Min
More
Show more items